200 related articles for article (PubMed ID: 32300953)
1. Cardiovascular and metabolic risk factors in patients with subclinical Cushing.
Petramala L; Olmati F; Concistrè A; Russo R; Mezzadri M; Soldini M; De Vincentis G; Iannucci G; De Toma G; Letizia C
Endocrine; 2020 Oct; 70(1):150-163. PubMed ID: 32300953
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.
Morelli V; Reimondo G; Giordano R; Della Casa S; Policola C; Palmieri S; Salcuni AS; Dolci A; Mendola M; Arosio M; Ambrosi B; Scillitani A; Ghigo E; Beck-Peccoz P; Terzolo M; Chiodini I
J Clin Endocrinol Metab; 2014 Mar; 99(3):827-34. PubMed ID: 24423350
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and outcomes of surgical versus conservative management in patients with subclinical Cushing's syndrome].
Liu MS; Zhang WJ; Zhu KY; Feng WH; Huang H; Zhu DL; Li P
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2834-2840. PubMed ID: 32988143
[No Abstract] [Full Text] [Related]
6. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.
Perogamvros I; Vassiliadi DA; Karapanou O; Botoula E; Tzanela M; Tsagarakis S
Eur J Endocrinol; 2015 Dec; 173(6):719-25. PubMed ID: 26330465
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
10. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
[TBL] [Abstract][Full Text] [Related]
11. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
Chiodini I; Morelli V; Salcuni AS; Eller-Vainicher C; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Pellegrini F; Copetti M; Beck-Peccoz P; Arosio M; Ambrosi B; Trischitta V; Scillitani A
J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
[TBL] [Abstract][Full Text] [Related]
12. Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.
Petramala L; Cavallaro G; Galassi M; Marinelli C; Tonnarini G; Concistrè A; Costi U; Bufi M; Lucia P; De Vincentis G; Iannucci G; De Toma G; Letizia C
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):69-75. PubMed ID: 28138953
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and metabolic consequences in patients with asymptomatic adrenal adenomas.
Hamidi O
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):277-282. PubMed ID: 33764928
[TBL] [Abstract][Full Text] [Related]
15. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes.
Emral R; Uysal AR; Asik M; Gullu S; Corapcioglu D; Tonyukuk V; Erdogan G
Endocr J; 2003 Aug; 50(4):399-408. PubMed ID: 14599113
[TBL] [Abstract][Full Text] [Related]
17. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.
Favero V; Aresta C; Parazzoli C; Cairoli E; Eller-Vainicher C; Palmieri S; Salcuni AS; Arosio M; Persani L; Scillitani A; Morelli V; Chiodini I
Cardiovasc Diabetol; 2023 May; 22(1):102. PubMed ID: 37131218
[TBL] [Abstract][Full Text] [Related]
18. Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.
Tsagarakis S; Vassiliadi D; Thalassinos N
J Endocrinol Invest; 2006 May; 29(5):471-82. PubMed ID: 16794373
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas.
Sbardella E; Minnetti M; D'Aluisio D; Rizza L; Di Giorgio MR; Vinci F; Pofi R; Giannetta E; Venneri MA; Vestri A; Morelli S; Lenzi A; Isidori AM
Eur J Endocrinol; 2018 May; 178(5):501-511. PubMed ID: 29510982
[TBL] [Abstract][Full Text] [Related]
20. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
